American International Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

American International Group’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,980	Closed	-$78	–	3364
2021 Q1	$78	Buy	2,980 +8	+0.3%	+$364	﹤0.01%	2830
2020 Q4	$107	Sell	2,972 -85	-3%	-$3.07K	﹤0.01%	2628
2020 Q3	$108K	Buy	3,057 +1,144	+60%	+$49.7K	﹤0.01%	2494
2020 Q2	$81K	Buy	1,913 +1,355	+243%	+$91.3K	﹤0.01%	2663
2020 Q1	$45K	Sell	558 -33	-6%	-$2.64K	﹤0.01%	2729
2019 Q4	$55K	Sell	591 -5	-0.8%	-$422	﹤0.01%	2856
2019 Q3	$45K	Sell	596 -4	-0.7%	-$307	﹤0.01%	2915
2019 Q2	$60K	Buy	+600	New	+$46.5K	﹤0.01%	2902

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

American International Group's EVFM Position: Q2 2021 in Review

American International Group sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2021, closing a stake of 2,980 shares — an estimated $78 sold.

American International Group first reported a position in EVFM in Q2 2019 and held it in 8 quarters. The position peaked at $108K in Q3 2020. 81 funds tracked by Wall St. Rank hold EVFM as of Q2 2021.

American International Group reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
American International Group sold 2,980 Evofem Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $78.
American International Group first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
American International Group's Evofem Biosciences, Inc. Common Stock position peaked at $108K in Q3 2020.
81 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.